PODD vs REX · P/E 34, rev $2.07B vs P/E 15, rev $642.5M
Insulet Corporation (PODD) versus REX American Resources Corporation (REX) — a side-by-side from cached financials, not a winner call.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Not investment advice. Open the PODD and REX stock pages for the full models.
Not investment advice.